Fact CheckerSign in

NCT06324448Completed

Self-administered tDCS for Improving Single- and Dual-task Gait in Patients With PD

Self-administered Transcranial Direct Current Stimulation for Improving Single- and Dual-task Gait in Patients With Idiopathic Parkinson's Disease: A Prospective, Single-center, Double-blind, Exploratory, Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 27 Apr 2026

Brief summary (registry, in English)

The purpose of this study is to investigate the efficacy and safety of self-administered transcranial direct current stimulation to improve the single- and dual-task gait in patients with Parkinson's disease.

Status (registry)
Completed
Study type
Interventional
Enrollment
24 (actual)
First submitted
13 Mar 2024
Start date
15 Feb 2024
Primary completion date
24 Feb 2026
Lead sponsor
Seoul National University Hospital
NCT number
NCT06324448

What you commit to

  • Study type: Interventional
  • Participants enrolled: 24
  • From 15 Feb 2024 to the primary completion date, 24 Feb 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Plan to adjust medication at the time of screening

Other illness

  • History of seizure
  • Metallic implants, such as cardiac pacemaker or an artificial cochlea
  • Parkinson's disease dementia; cut-off is \< 7 of Korean-Montreal Cognitive Assessment for illiterate patients, \< 13 for those educated for 0.5-3 years, \< 16 for 4-6 years of education, \< 19 for 7-9 years of education, and \< 20 for 10 or more years of education.
  • Uncontrolled vestibular disease, orthopedic hypotension, or paroxysmal vertigo

Other

  • Patients with inflammation, burns, or wounds in the stimulation area
  • Severe dyskinesia or severe on-off phenomenon
  • Other neurological, orthopedic, or cardiovascular co-morbidities significantly affecting gait function
  • Pregnant or lactating patients
  • Other comorbidities that make it difficult to participate in this study

Who the study is looking for

  • Clinically diagnosed as idiopathic Parkinson's disease by neurologists according to the UK Parkinson's Disease Society Brain Bank criteria
  • modified Hoehn \& Yahr stage 2, 2.5, or 3

Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Seoul National University Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.